TREA

79391171 - ZYTOMICS

Follow

Information

  • Trademark
  • 79391171
  • Serial Number
    79391171
  • Filing Date
    November 01, 2023
    a year ago
  • Transaction Date
    March 06, 2025
    2 months ago
  • Status Date
    March 06, 2025
    2 months ago
  • Location Date
    March 06, 2025
    2 months ago
  • Status Code
    661
  • Current Location
    TMEG LAW OFFICE 103
    Employee Name
    BECKER, MARY
  • Attorney Docket Number
    61016.003U1
    Attorney Name
    Laurence P. Colton
    Law Office Assigned Location Code
    L30
  • Owners
Information
Mark Drawing Code
4
Mark Identification
ZYTOMICS
Case File Statements
  • GS0091: Scientific research and laboratory apparatus in the nature of analysis systems for use in the analysis of proteins, nucleic acids, human cells, and human tissues; educational apparatus and simulators in the nature of medical diagnostic simulators for use as teaching aids for medical procedures; analysis apparatus in the nature of diagnostic apparatus for research laboratory use for conducting and evaluating histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, polymerase chain reaction (PCR), next generation sequencing (NGS), microarray hybridisation in the nature of genetic chip or biochip hybridisation, flow cytometry, and isolation of biomolecules including DNA, RNA and proteins; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; analysis apparatus for research laboratories in the nature of diagnostic apparatus for measuring, testing and examining tissue, cells and biomolecules including DNA, RNA and proteins
  • GS0051: Pharmaceuticals and medical preparations for use in chemotherapy and cancer diagnostics; diagnostic preparations for medical purposes; diagnostic preparations for in-vitro testing for medical use; pharmaceuticals, pharmaceutical preparations, medical products in the nature of diagnostic preparations, medical preparations, chemical products in the nature of chemical reagents, chemical preparations, biochemical products in the nature of chemical reagents, and biochemical preparations, all for use in chemotherapy and cancer diagnotics for medical use; pharmaceutical, medical, chemical and biochemical preparations for medical purposes in the fields of histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, polymerase chain reaction (PCR), next generation sequencing (NGS), microarray hybridisation in the nature of genetic chip or biochip hybridisation, flow cytometry services, and isolation of biomolecules including DNA, RNA and proteins; nucleic acids in the nature of DNA, RNA, oligonucleotides, polynucleotides, marked nucleic acids and modified nucleic acids for medical purposes; proteins in the nature of peptide substrates, recombinant proteins and marked proteins for use in chemotherapy and cancer diagnostics for medical purposes; antibodies for medical purposes; DNA probes being biochemical preparations for chemotherapy and cancer diagnostics for medical use; RNA probes being biochemical preparations for chemotherapy and cancer diagnostics for medical use; oligonucleotide probes being biochemical preparations for chemotherapy and cancer diagnostics for medical use; biological tissue, namely, human stem cells, human somatic cells, human cancer cells, human tissue, and human tissue sections for use in chemotherapy and cancer diagnostics; nucleic acids, proteins,human somatic cells, human cancer cells and human stem cells immobilised on carriers for medical diagnostic purposes
  • GS0351: Business management consultancy and advisory services; operation of a business for others, namely, holding company services; holding company services performed for third parties, namely, business management, business administration, providing office functions; holding company services performed for third parties, namely developing marketing strategy, professional business and organisational consultancy and management of the business interests of others and legally independent companies; business management and organization consultancy; advisory services for business management; business administration; providing office functions; planning and monitoring of business developments with regard to organisational matters in the nature of business organisational consultation
  • GS0011: Chemicals for use in industry and science; chemicals and biochemicals for use in science in the fields of pathology, genetics, human genetics, molecular pathologies, molecular biology, microbiology, biotechnology, laboratory medicine; chemicals and biochemicals for use in science in the fields of histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, polymerase chain reaction (PCR), next generation sequencing (NGS), microarray hybridisation in the nature of genetic chip or biochip hybridisation, flow cytometry services, and isolation of biomolecules including DNA, RNA and proteins; nucleic acids in the nature of DNA, RNA, oligonucleotides, polynucleotides, marked nucleic acids and modified nucleic acids, for scientific purposes; proteins in the nature of peptide substrates, recombinant proteins and marked proteins for scientific and medical research; antibodies for scientific purposes; DNA probes being biochemical preparations for scientific purposes; RNA probes being biochemical preparations for scientific purposes; oligonucleotide probes being biochemical preparations for scientific purposes; biological tissue, namely, human stem cells, human somatic cells, human cancer cells, human tissue, human tissue sections, for scientific and medical research; nucleic acids, proteins, human somatic cells, human cancer cells, and stem cells immobilised on carriers for scientific and medical research
  • GS0441: Medical services; medical diagnostic services; medical in-vitro diagnostic services for medical and pharmaceutical purposes; medical services in the fields of pathology, genetic science, human genetics, molecular pathologies, molecular biology, microbiology, biotechnology and laboratory medicine; medical diagnostic services using histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, polymerase chain reaction (PCR), next generation sequencing (NGS), microarray hybridisation in the nature of genetic chip or biochip hybridisation, flow cytometry and isolation of biomolecules including DNA, RNA and proteins; medical counseling; pharmaceutical services in the nature of developing pharmaceuticals for diagnosing and treating cancer; pharmaceutical advice; medical and health clinic services relating to DNA, genetics and genetic testing; medical pathology services; genetic testing for medical purposes
  • GS0101: Medical apparatus and instruments for use in cancer diagnostic and treatment procedures; medical instruments for use in cancer diagnostic and treatment procedures; medical analytical apparatus for analyzing human cells and tissues for the presence of cancerous cells for medical purposes; automatic analyzers for medical diagnosis of human cells and tissues; physical analyzers for diagnosing cancer for medical use; genetic testing apparatus for medical purposes
  • GS0421: Science and technology services, namely, research in the field of cancer; medical research laboratory services; development of pharmaceutical preparations and medicines; clinical research in the field of cancer diagnosis and treatment for medical and scientific purposes; research relating to biotechnology; scientific research consultancy services; biological analysis, biochemical analysis, chemical analysis, scientific analysis, all being scientific research; scientific research in the field of genetics and genetic engineering
Case File Event Statements
  • 3/14/2024 - a year ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 3/22/2024 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 4/24/2024 - a year ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 5/30/2024 - 11 months ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/31/2024 - 11 months ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/4/2024 - 11 months ago
    9 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 6/4/2024 - 11 months ago
    6 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 6/4/2024 - 11 months ago
    8 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 6/4/2024 - 11 months ago
    7 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 3/6/2025 - 2 months ago
    15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/6/2025 - 2 months ago
    14 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/6/2025 - 2 months ago
    16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/9/2025 - 3 months ago
    13 - REFUSAL PROCESSED BY IB Type: RFNT
  • 12/27/2024 - 4 months ago
    10 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 1/22/2025 - 3 months ago
    12 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 1/22/2025 - 3 months ago
    11 - REFUSAL PROCESSED BY MPU Type: RFRR